
Oncologist

No OPD information available
Prostate Cancer
Renal Cell Carcinoma (RCC)
Adult Soft Tissue Sarcoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Human Papillomavirus Infection
Liver Cancer
Lung Cancer
Prostatectomy
David I. Pryor is a male healthcare provider who helps patients with different types of cancer like Prostate Cancer, Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, Head and Neck Squamous Cell Carcinoma, Human Papillomavirus Infection, Liver Cancer, Lung Cancer, and Prostatectomy.
David I. Pryor uses special skills and treatments to care for patients with cancer. He talks to patients in a kind and clear way, making them feel comfortable and safe. Patients trust him because he listens to their concerns and answers their questions.
David I. Pryor stays updated with the newest medical knowledge and research to give the best care to his patients. He works with other medical professionals like doctors and nurses to make sure patients get the right treatment.
David I. Pryor's work has helped many patients live healthier lives. His research paper "Update of clinical practice guidelines for the management of patients with sarcoma" was published in a medical journal. He is also involved in a clinical trial called "Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET."
David I. Pryor's dedication to his patients and his contributions to medical research have had a positive impact on many people's lives. Patients trust him, and his work is helping to improve treatments for cancer.
Enrollment Status: Active not recruiting
Published: February 06, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
